EPRX Eupraxia Pharmaceuticals Inc.

6.138USD8.780 CAD · TSX-0.90%Mkt Cap: 412.87M USDP/E: —

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…